A first-of-its-kind stem cell-based treatment for retinitis pigmentosa developed by UC Irvine's Dr. Henry Klassen, Dr. Jing Yang and colleagues has received consent from the U.S. Food & Drug Administration for use in a clinical ...
May 7, 2015
0
48
A team led by Stanford University researchers has developed a wireless retinal implant that they say could restore vision five times better than existing devices.
Apr 28, 2015
0
305
New research from The University of Manchester published in the Journal of Community Genetics reveals a stark variation in genetic testing services for inherited eye disease in England.
Mar 31, 2015
0
14
Researchers have developed an antioxidant gene therapy that slows cone-cell death and prolongs vision in mouse models of retinal degeneration.
Mar 24, 2015
0
56
An exhaustive hereditary analysis of a large Louisiana family with vision issues has uncovered a new gene tied to an incurable eye disorder called retinitis pigmentosa, according to an examination led by scientists at The ...
Jan 16, 2015
0
13
A new genetic therapy helped blind mice and dogs regain some sensitivity to light - enough for the mice to distinguish flashing from non-flashing lights - setting the stage for future clinical trials in humans.
Dec 8, 2014
0
0
Sildenafil, the active ingredient in the erectile dysfunction drug Viagra, could cause unusual visual responses in people who carry a common mutation for eye disease and may have long-term detrimental effects on their vision, ...
Sep 30, 2014
0
0
Eye doctor Dr. Toshihiko Matsuo and polymer science engineer Dr. Tetsuya Uchida have been developing a new type of retinal prosthesis that is based on a photoelectric dye. The photoelectric dye is an organic molecule that ...
Sep 30, 2014
0
0
Cystoid macular edema (CME) is a common complication of retinitis pigmentosa (RP), a family of retinal diseases in which patients typically lose night and side vision first and then develop impaired central vision. CME can ...
Jul 21, 2014
0
0
(Medical Xpress)—Columbia University Medical Center (CUMC) researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa (RP), a leading cause of vision loss. The approach, ...
Jul 10, 2014
0
59
